| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,709 |
14,989 |
$1.27M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,592 |
10,445 |
$607K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
21,990 |
15,398 |
$604K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
8,570 |
5,565 |
$472K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,696 |
3,166 |
$412K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
30,083 |
11,153 |
$313K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16,315 |
11,919 |
$170K |
| 99051 |
|
2,539 |
1,838 |
$33K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
558 |
311 |
$16K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
365 |
297 |
$16K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
179 |
124 |
$7K |
| 87807 |
|
548 |
397 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
181 |
112 |
$5K |
| 81003 |
|
581 |
463 |
$962.50 |
| 81025 |
|
137 |
113 |
$740.82 |
| 71046 |
Radiologic examination, chest; 2 views |
49 |
40 |
$473.86 |
| 99000 |
|
1,273 |
1,028 |
$23.06 |
| 99070 |
|
20 |
15 |
$9.42 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
16 |
12 |
$0.00 |
| 94760 |
|
233 |
101 |
$0.00 |